aTyr Pharma (LIFE) Announces Additional Data on Resolaris Phase 1b/2; Reaffirms Encouraging Results
Tweet Send to a Friend
aTyr Pharma, Inc. (Nasdaq: LIFE) announced that additional clinical data from aTyr's Phase 1b/2 Trial (002) in adult patients with ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
